IgG2c inhibitors are a class of chemical compounds that specifically target the IgG2c subclass of immunoglobulins, primarily studied in murine (mouse) models. IgG2c is an analog of the IgG2a subclass found in certain mouse strains, such as C57BL/6, and is involved in immune responses, particularly in the recognition and neutralization of foreign antigens. The structural characteristics of IgG2c, like other IgG subclasses, include a highly conserved Fc region responsible for engaging with Fc receptors on immune cells, and Fab regions that interact with antigens. IgG2c inhibitors are designed to block these interactions, providing a means to modulate the function of IgG2c in various biological processes. By inhibiting IgG2c, these compounds can interfere with its ability to bind to cellular receptors or engage in immune complex formation, leading to alterations in immune signaling and cell communication.
The molecular design of IgG2c inhibitors focuses on targeting specific regions of the IgG2c molecule that are crucial for its function. These inhibitors may bind to the Fc region, preventing interactions with Fc gamma receptors, or to the Fab region, disrupting antigen recognition. The binding of these inhibitors typically involves a combination of non-covalent interactions such as hydrogen bonding, ionic interactions, and hydrophobic forces, ensuring a high degree of specificity and stability in the inhibitor-IgG2c complex. Researchers use these inhibitors to dissect the unique roles that IgG2c plays in immune regulation and its interactions with various cellular components. By studying the effects of IgG2c inhibition, scientists gain valuable insights into the broader mechanisms of immunoglobulin function and the role of different IgG subclasses in immune system dynamics.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclophosphamide | 50-18-0 | sc-361165 sc-361165A sc-361165B sc-361165C | 50 mg 100 mg 500 mg 1 g | $76.00 $143.00 $469.00 $775.00 | 18 | |
Cyclophosphamide could downregulate IgG2c expression through its cytotoxic effects on B-cell precursors, impairing the clonal expansion necessary for robust antibody production. | ||||||
Cortisone | 53-06-5 | sc-207455 | 5 g | $230.00 | ||
Cortisone may decrease IgG2c levels by suppressing the transcription of genes critical for B-cell activation and differentiation, thereby reducing the immune system's ability to produce specific antibodies. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $76.00 $255.00 | 18 | |
By inhibiting ribonucleotide reductase, Hydroxyurea could decrease the pool of deoxyribonucleotides, leading to a reduction in B-cell proliferation and consequent downregulation of IgG2c synthesis. | ||||||
Fludarabine | 21679-14-1 | sc-204755 sc-204755A | 5 mg 25 mg | $57.00 $200.00 | 15 | |
Fludarabine might reduce IgG2c expression by causing DNA chain termination during B-cell replication, resulting in apoptosis and a subsequent decrease in antibody-secreting plasma cells. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $65.00 $210.00 | 26 | |
This glycolytic inhibitor could reduce IgG2c expression by starving B-cells of energy, leading to cellular stress and potentially triggering apoptosis before differentiation into IgG2c-secreting cells. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $100.00 $230.00 $450.00 $1715.00 $2900.00 | 4 | |
As a microtubule disruptor, Vinblastine may inhibit B-cell mitosis, leading to a decreased population of IgG2c-expressing plasma cells. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Propranolol may decrease IgG2c expression by blocking beta-adrenergic signaling, which can suppress B-cell activation and antibody production due to reduced sympathetic nervous system input. | ||||||
Chlorambucil | 305-03-3 | sc-204682 sc-204682A | 250 mg 1 g | $51.00 $120.00 | 3 | |
Chlorambucil could downregulate IgG2c by alkylating DNA in B-cells, thereby disrupting their replication and function, resulting in reduced antibody synthesis. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $98.00 $315.00 $2244.00 $4396.00 $17850.00 $34068.00 | 3 | |
Colchicine binds to tubulin, preventing microtubule polymerization, which could decrease B-cell division and lower the number of cells available to produce IgG2c. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $25.00 $117.00 $209.00 | 27 | |
Imatinib might reduce IgG2c expression by selectively inhibiting B-cell tyrosine kinases, leading to reduced cell division and proliferation of IgG2c-secreting cells. | ||||||